Deutsche Bank Maintains Buy on Cellebrite DI, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Jamie Shelton has maintained a Buy rating on Cellebrite DI (NASDAQ:CLBT) and raised the price target from $15 to $18.

August 16, 2024 | 5:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank analyst Jamie Shelton has maintained a Buy rating on Cellebrite DI and raised the price target from $15 to $18.
The Buy rating and increased price target from a reputable analyst at Deutsche Bank are likely to positively influence investor sentiment and drive short-term price appreciation for CLBT.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100